2,026 followers
@ResidentsMDBlog Agreed. Not sure I’d stop using Apixaban just for the advantage of once daily dosing. Thought you might appreciate this analysis https://t.co/vLGcU3xgLp
@ResidentsMDBlog Agreed. Not sure I’d stop using Apixaban just for the advantage of once daily dosing. Thought you might appreciate this analysis https://t.co/vLGcU3xgLp
#HealthEconJA Cost-Effectiveness Analysis of Apixaban Versus Edoxaban in Patients with Atrial Fibrillation for Stroke Prevention https://t.co/PSpUjGj9I7